Sage Journals: Discover world-class research

Abstract

Numerous amphiphilic cationic drugs cause generalized phospholipidosis in animals; one of these drugs is the Sandoz compound 200–125, a psychotropic agent. During a 6-month toxicity study in Charles River CD rats, a dramatic increase in foamy macrophages was seen in the lungs. A follow-up experiment was done to study the pathologic basis of these changes including a reversibility phase. Generalized phospholipidosis was induced after 4 weeks of 500 mg/kg/day of 200–125 by gavage. Characteristic pulmonary lesions consisted of extensive accumulations of large pale foamy macrophages as well as granular eosinophilic extracellular material. Lipid analyses of lungs showed marked increases in phospholipids (144%) and cholesterol esters (110%) in rats treated with 200–125. Drug metabolism studies employing ¹⁴C-labeled 200–125 showed an affinity for the drug to concentrate in the lungs and lymphoreticular system (spleen, lymph nodes) as well as in the adrenals, liver, and kidney. Reversibility of the phospholipidosis was nearly complete 4 weeks after drug withdrawal. The tissue changes were characterized by transmission and scanning electron microscopy. The potential pulmonary toxicity in humans with the amphiphiles is discussed.

References

1. Cheville NF (1976). Respiratory System. In: Cell Pathology, NF Cheville (ed). Iowa State University Press, Ames, Iowa, pp. 325–330.

2. Costa-Jussa, FR , Corrin B , and Jacobs JM (1984). Amiodarone lung toxicity: A human and “experimental study”. J. Pathol. 143:73–79.

3. Folch J , Lees M , and Sloane-Stanley GH (1957). A simple method for isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497–509.

4. Hassenpflug J (1976). Further studies on the structure-activity relationships of drugs inducing lipidosislike ultrastructural alterations. Naunyn-Schmiedeberg's Arch. Pharmacol. 293: R57.

5. Hosteller K (1984). Molecular studies of the reaction of cellular phospholipidosis by cationic amphiphilic drugs. Fed. Proc. 43:2582–2585.

6. Karabelnik D , Zbinden G , and Baumgartner E (1974). Drug-induced foam cell reactions in rats. I. Histopathologic and cytochemical observations after treatment with chlorphentermine, RMI-10393 and RO 4-4318. Toxicol Appl. Pharmacol. 27:395–407.

7. Kessler G and Lederer H (1965). Fluorometric measurement of triglycerides. In: Automation in Analytical Chemistry, LT Skeggs (ed). Media Incorporated, New York, pp. 341–344.

8. Kikkawa Y and Suzuki K (1972). Alterations of cellular and acellular alveolar and bronchiolar walls produced by the hypocholesteremic drug AY-9944. Lab. Invest. 26:441–447.

9. Lie RF , Schmitz JM , Pierre, KJ , and Gochman N (1976). Cholesterol oxidase-base determination, by continuous flow analysis, of total and free cholesterol in serum. Clin. Chem. 22:1627–1630.

10.

10. Lullmann H , Lullmann-Rauch, R , and Wasserman O (1978). Lipidosis induced by amphiphilic cationic drugs. Biochem. Pharmacol. 27:1103–1108.

11.

11. Lullmann H and Lullmann-Rauch R (1981). Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses. Toxicol. Appl. Pharmacol. 61:138–146.

12.

12. Lullmann-Rauch R (1974). Lipidosis-like ultra-structural alterations in rat lymph nodes after treatment with tricyclic antidepressants or neuroleptics. Naunyn-Schmeideberg's Arch. Pharmacol. 286:165–179.

13.

13. Lullmann-Rauch R and Reil G (1974). Chlorphentermine-induced lipidosislike ultrastructural alterations in lungs and adrenal glands of several species. Toxicol. Appl. Pharmacol. 30:408–421.

14.

14. Lullmann-Rauch R (1979). Drug-induced lysosomal storage disorders. In: Lysosomes in Applied Biology and Therapeutics JT Dingle , RJ Jacques , and IH Shaw (eds). North-Holland, Amsterdam, Vol. 6, pp. 49–130.

15.

15. Lullmann-Rauch R and Nassberger L (1983). Citalopram-induced generalized lipidosis in rats. Acta Pharmacol. Toxicol. Copenh.) 52:161–167.

16.

16. Rakita L , Sobol SM , Mostow N , and Vrobel T (1983). Amiodarone pulmonary toxicity. Am. Heart J. 106:906–916.

17.

17. Reasor MJ (1981). Drug-induced lipidosis and the alveolar macrophage. Toxicology 20:1–33.

18.

18. Reasor M (1984). Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs. Fed. Proc. 43:2578–2581.

19.

19. Rhodin JAG (1974). Respiratory system. In: Histology: A Text and Atlas, J Rhodin (ed). Oxford University Press, New York, pp. 624–638.

20.

20. Schmien R , Seiler KU , and Wasserman O (1974). Drug induced phospholipidosis. I. Lipid composition and chlorphentermine content of rat lung tissue and alveolar macrophages after chronic treatment. Naunyn-Schmiedeberg's Arch Pharmacol. 283:331–334.

21.

21. Seiler KU and Wassermann O (1975). Drug-induced phospholipidosis. II. Alterations in the phospholipid pattern of organs from mice, rats and guinea pigs after chronic treatment with chlorphentermine. Naunyn-Schmeideberg's Arch. Pharmacol. 228:261–268.

22.

22. Seydel JK and Wassermann O (1976). NMR studies on the molecular basis of drug-induced phospholipidosis. II. Interaction between several amphiphilic drugs and Phospholipids. Biochem. Pharmacol. 25:2357–2364.

23.

23. Shikata T , Kanetaka T , Endo Y , and Nagashima K (1972). Drug-induced generalized phospholipidosis. Acta Pathol. Jpn. 22:517–531.

24.

24. Shio H , Fowler S , Bhuyaneswaran C , and Morris M (1982). Lysosome lipid storage disorder in NCTR-BALB/c mice. Am. J. Pathol. 108:150–159.

25.

25. Spaet RH , Sullivan DJ , and Diener RM (1983). Occurrence of myeloid bodies in rats following two-year administration of imipramine hydrochloride. Toxicol. Pathol. 11:3–11.

26.

26. Stoeckenius W (1962). Some electron microscopic observations on liquid crystalline phases in lipid-water systems. J. Cell Biol. 12:221–229.

27.

27. Weiss L and Greep R (1977). The respiratory system. In: Histology, L Weiss and R Greep (eds). McGraw-Hill Book Company, New York, pp. 802–813.

28.

28. Whitley RW and Alburn HE (1965). A semi-automated method for the determination of serum phospholipids. Ann. N. Y. Acad. Sci. 130:634–646.

Generalized Phospholipidosis Induced by an Amphiphilic Cationic Psychotropic Drug

Abstract

References